Cargando…
Impact of Aspirin Use on Outcomes in Patients With Hepatocellular Cancer: A Nationwide Analysis
BACKGROUND: Despite the use of new immunotherapies, hepatocellular carcinoma (HCC) has a poor survival rate. Through multiple molecular mechanisms, aspirin (ASA) has demonstrated a reduced incidence of HCC, however, the impact of long-term ASA use on in-hospital outcomes has not been studied. METHOD...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elmer Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284635/ https://www.ncbi.nlm.nih.gov/pubmed/37350804 http://dx.doi.org/10.14740/wjon1601 |